Cervical cancer affects more than half a million women annually causing more than 300,000 deaths. Detection of cancer in its early stages is essential to eradicate the disease from the patient's body.
A new study combines cfDNA fragmentomes and protein biomarkers to vastly improve early detection of ovarian cancer, offering a cost-effective and robust tool for mass screening. Study: Early detection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results